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CHAPTER 1
INTRODUCTION
A quiet epidemic, the Human Papilloma Virus (HPV) is a sexually transmitted disease
(STD), which is the leading cause of genital warts and cervical cancer in women (Markowitz,
2001). According to American Teacher (2007), a debate exists among parents regarding use of
the cervical cancer vaccine named Gardasil, which is being manufactured by Merck & Co. The
U.S. Food and Drug Administration approved this vaccine on June 8, 2006. The HPV vaccine
intended to be administered to young girls and women ages nine through twenty six. The
purpose of the vaccine is to help minimize the risk of cervical cancer.
Vaccine Concerns
According to NCSL (2011), CDC reports that approximately 20 million people in the
United States are infected with HPV. There is no treatment for HPV as there are 30 strains of
HPV that can affect at least half of sexually active people and there are no symptoms of which
can disappear on their own (NCSL, 2011). Merck’s Gardisil is a vaccine that can target four
strands of HPV that are linked to cervical cancer and genital wart cases (NCSL, 2011). A
societal concern is that the vaccine may encourage young girls to become sexually active
(Caputo, 2007). “It seems unlikely that a vaccine that prevents a small number of sexually
transmitted infections which have no symptoms will cause girls to be promiscuous or have
unsafe sex, as some have suggested” (NNII, 2007 p.3). One parent, Brenda Jannsen, expressed
her disagreement to the vaccine as she has taught her children against pre-marital sex and she
believes that if the vaccines are required by the government that will give teenagers the idea
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that pre-marital sex is ok (Caputo, 2007). Another concern of the use of the vaccine is the
acceptance factor as those who approve of the vaccine may disagree with mandating it for
student immunization. The reason is because there are concerns about the drug costs, safety
and parental rights (NCSL, 2011).
It is not known if the vaccine has adverse side effects resulting from long- term effects.
“Since our experience with this new vaccine is limited and not all women are exposed to high
risk HPVs, some girls could experience rare vaccine adverse events not yet identified without
a corresponding benefit”(NNII, 2007 p.3). The duration of the vaccine is unclear. Current
studies indicate that the vaccine is effective for at least five years and there is research still
being done to determine how long the protection will last (CDC, 2006).
Operational Definitions
Gardasil is one of the first vaccines developed for HPV and was licensed by the FDA
in June 2006. Gardisil protects against HPV types 6, 11, 16, and 18 (CDC, 2006). The vaccine
has been recommended to be administered to girls between the ages of 11-12 or as early as the
age of 9. It is recommended that the vaccine is administered prior to the onset of sexual activity
(CDC, 2006). According to NNII (2007), it is also recommended that the vaccine be
administered to females who may be sexually active, but have not yet been exposed to HPV.
Gardisil has been tested on over 11,000 females (9-26 years of age) throughout various
countries to include the United States (CDC, 2006). The clinical trials have proven to be 100%
effective in preventing these specific strains of HPV (Kaiser, 2007). Despite the proven clinical
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trials, there is a constant debate as to whether the vaccine should be a required vaccine for
school aged girls.
The adverse side effects of the vaccine are a major concern for many parents. “The
most common side effects with Gardasil are: pain swelling, itching, bruising and redness at the
injection site; headache; fever; nausea; dizziness; vomiting, and fainting” (Merck & Co., 2012
p.1). Long term side effects are unknown due to the originality of the vaccine. According to
CDC (2006), in June 2006, the ACIP voted to recommend the first vaccine developed to
prevent cervical cancer and other diseases in females caused by certain types of genital HPV.
Gardisil protects against four types of HPV of which 70% causes cervical cancer and 90%
causes genital warts. The vaccine has been recommended for girls and women ages nine to
twenty six only. The HPV vaccine is administered through a series of three shots over a 6month period. (CDC, 2006). Females should be given the vaccine before they are sexually
active. The vaccine is most effective in girls/women who have not yet acquired any of the four
HPV types covered by the vaccine. However, females who are sexually active may also benefit
from the vaccine. Very few young women are infected with all four types of these HPV types.
Thus, they would still get protection from those types they have not acquired (CDC, 2006).
Legal Limitations
Gardasil has been suggested as a mandatory vaccine to administer to girls before
entering high school. According to Lancet (2006 p.1), “The Michigan Senate passed a bill on
September 21, 2006, ruling that all girls entering sixth grade of school should be immunized.”
Despite Michigan’s acceptance of this bill, it wasn’t received the same in other states,
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therefore, the bill was not enacted in each state. For instance, in 2007, Texas Governor Rick
Perry supported the bill, but it was rejected by legislation (Dart, 2011). Due to concerns about
Gardisil, the federal panel opposed mandating it as a condition of school enrollment (Dart,
2011). According to Dart (2011), Texas lawmakers approved a bill which prohibits officials
from requiring administration of the vaccine for four years. According to NCLS (2011), since
2006, in at least 41 states plus Washington, D.C., legislation has introduced the bill to require
the vaccine, fund, or educate the public about the HPV Vaccine, and at least 20 states have
enacted legislation. One of the debates for the use of the HPV vaccine is that the quadrivalent
HPV vaccine will not eliminate the need for cervical cancer (Markowitz, 2007). Reason being,
not all HPV types that cause cervical cancer are included in the contents of the vaccine
(Markowitz, 2007).
What is HPV?
A major component of contracting HPV is the risk of having genital warts or cervical
cancer. HPV is a disease that can be contracted by oral, vaginal penetration, and rubbing of the
genitals. The use of condoms may not prevent the contraction of HPV, but it can certainly
decrease the chances of contraction. According to NNII (2007), does state that the consistent
use of condoms can be related to whether HPV will progress to cervical cancer. If a woman
has a sexually transmitted disease and it is not treated or it is a reoccurring disease it can aid to
the progression of having cervical cancer.
A person can contract the disease and be unaware because the symptoms may be
dormant and in a non-detective state. HPV can lead to cervical cancer which is why the
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discussion of vaccine use is debated whether it is necessary to require for administration
starting with school age children and teenagers to help prevent the transmission of HPV once
a person becomes sexually active. Another question is if the vaccine is effective for women
who are already sexually active. HPV can be detected through pap smears. Irregular results
from a pap smear would lead to a repeat checkup in six months. Males may never know that
they have contracted it because genital warts may not develop and they have a low risk of
developing anal or penile cancer, therefore, the signs of transmission is not easily detected.
Many are misdiagnosed when genital warts appear because they are diagnosed with having
herpes. According to Markowitz (2007 p.2), “Genital HPV is the most common sexually
transmitted infection in the United States; an estimated 6.2 million persons are newly infected
every year.” Unfortunately, HPV has not received the same national attention as other STDs
despite the high number of cases. According to Markowitz (2007), it was reported in 2007 that
an estimated 11, 100 cases were diagnosed and approximately 3,700 will die from cervical
cancer.
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CHAPTER 2
LITERATURE REVIEW
According to Mayeux (2005), the way to help people accept the vaccine is provide
education and awareness of HPV and the vaccine. Persistent genital HPV infection can cause
cervical cancer in women to include other types of anogenital cancers and genital warts in both
men and women (Markowitz, 2007). It is important to understand that there are high and low
risks of HPV. Low risk types can cause benign cervical cell changes and genital warts. Highrisk types act as carcinogens in the development of cervical and other anogenital cancer
(Markowitz, 2007). “The FDA acknowledges that sexual activity with multiple partners is an
essential part of the lifecycle of this virus” (Harrub, 2006 p.1-2). Continued education of the
risk of cycling sexual activity is a must to help people understand that HIV/AIDS and other
STD’s are not the only concerns of changing sexual partners. Once people learn that HPV is
not like other STD’s as it is a gateway that leads to cancerous diseases that can be challenging
to cure.
Many parents are concerned that the HPV school vaccination is only for girls. A school
vaccination should not be required for one gender. The vaccine was approved for boys and
young men in 2009 that protects against genital warts and is not recommended for pregnant
women. Markowitz’s (2007) review of the vaccine states that, despite the low rates of genital
warts, anal and penile cancers, men may still benefit from the vaccine as well. However, there
has not been enough research to show the effectiveness in either of these categories. Data in
2007, stated that the HPV vaccine is not licensed to administer to males due to lack of data
provided for the efficacy in males for any age category (OHSU, 2007). The more information
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acquired about HPV, the better. Abstaining from sexual activity is the surest way to prevent
genital HPV infection. Otherwise, a monogamous relationship with an uninfected partner is a
secondary strategy to help prevent future genital HPV infections.
The idea of making the HPV vaccine mandatory in schools has been debated by
legislation. There are no federal laws that require girls or adolescent females to get vaccinated
for cervical cancer or genital warts. The other issue or concerns regarding the HPV vaccine
are: parental concerns, decrease of cervical cancer screening, and questions regarding
effectiveness of vaccine. A parental concern is whether administering the vaccine to girls will
encourage sexual activity and lead to adverse effects. The second concern is whether
immunized women will stop seeking cervical cancer screenings. Finally, another concern is if
the vaccine will actually reduce transmission. (NNII, 2007)
The CDC requires vaccinations to protect children from various types of disease. As
for the HPV vaccination, the CDC has made universal recommendation for school age girls to
receive the vaccination. The universal recommendation is to help remove a stigma associated
with the HPV vaccine and make the vaccine eligible for funding (NNII, 2007). Most states
permit religious and /or philosophical exemptions, in addition to exemption for medical
contraindications. The discussion of the HPV vaccine is so that it can be added to the list of
vaccines that is currently required for children to attend school. There have to be a lot of
questions answered before all United States legislations will be onboard with this vaccine
requirement.
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Due to Merck being the only company currently producing the vaccine, they have a
huge financial incentive to persuade states to mandate Gardasil. However, the controversy of
the vaccine has caused Merck to lobbying its push to have state lawmakers require the vaccine
for preteens (American Teacher, 2007). After word was out on the fact that Texas Gov. Rick
Perry gained financial contributions from Merck to mandate the vaccine, the state House
rescinded the order (American Teacher, 2007). According to American Teacher (2007), the
push for mandate is the cause for the controversy stir rather than the vaccine itself. “The Texas
Medical Association advises: Mandating a vaccine for a disease not spread by casual and/or
occupational contact, only available to one gender represents considerable departure from past
practice” (American Teacher, 2007, p.4). Many parents are confused on whether to have their
daughter vaccinated or not due to their son is not required to receive the same vaccination. “On
the other hand, Jo-Ann Lynch, a member of the Albuquerque, N.M. Teachers Federation, is a
cervical cancer survivor who believes mandating the vaccine for school use is good”
(American Teacher, 2007, p.4). In New Mexico, lawmakers are considering legislation that
would require sixth grade girls be vaccinated for the HPV disease. According to American
Teacher (2007), parents are hesitant to discuss cervical cancer with a twelve year old. Another
concern of the vaccine mandate is that it will be considered a license for sexual activity among
young adults (American Teacher, 2007). Vaccine or not parents need to talk to their children
about diseases spread through sexual intercourse.
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CHAPTER 3
METHODOLOGY
Research design
The knowledge of the drug Gardasil for cervical cancer, and HPV based on data
collected through surveys administered will be reviewed. A survey was administered to
collect data for further discussion of this topic. The demographics of the surveyors will also
be explored to determine if it’s a significant factor of the survey results. Homogeneous
selection of participants were used to conduct the experiment due to the fact that the
independent variables are women or gender specific. This procedure will be used to control
the gender of the experiment. Women were randomly assigned individuals to take the survey.
The participants were women who are also mothers located either in the inner-city or rural
area. It was important to attain information from mothers on their knowledge of HPV, the
HPV vaccine, whether they would want the HPV immunization be a requirement or optional
and how they will most likely seek information on HPV and the HPV vaccine.
Research Hypothesis
The hypothesis of the study is that the results will prove that lack of knowledge of
HPV and the HPV vaccine can contribute to the decision of a mother allowing her school age
child to be administered the vaccine whether by school mandate or voluntarily.
Research Protocol
Assistance was requested from an educator colleague to administer the survey
(Appendix B) to the sample of women in the state of Michigan in the rural area and the
primary surveyor administered the survey to women in the inner-city. A letter was distributed
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to each participant providing information on the purpose of the survey and request for
completion (Appendix A) prior to completing the survey.
Sample
The survey was administered to forty-three women from Michigan who identified
themselves as mothers. The sample included 20 white females and 23 black females who
completed the survey. Thirty-nine of the participants had children between the ages of nine to
nineteen and four had children either below the age of nine or older than nineteen. The data
was computed through a one-way sample (Table 3) and ANOVA (Table 4) to analyze the
participant responses to the questions regarding the knowledge of HPV, the HPV vaccine and
whether that affects the participant’s decision to allow their daughter to receive the vaccine
and their opinion as to whether they believe the vaccine should be school mandated.
Instrument
Participants completed the Survey on Parental Choice for HPV for Daughters
(Appendix B). The survey was designed to be anonymous, therefore, participants would not
have to be concerned with the identity of their answers being disclosed in reporting. The
questionnaire consisted of three subscales and sixteen questions. These subscales measured the
age of daughter to correlate the age groups to the question on the mother’s willingness to have
their daughter vaccinated, the mother’s willingness to have daughter vaccinated as school
mandate, the mother’s knowledge of HPV and HPV vaccine, and the demographics of the
mothers to include race, and marital status.
Data Analysis
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The data analysis techniques that will be used include review of survey data through
SPSS output of results. Each survey will be reviewed and the data from each survey will be
tallied according to each question. As the numbers of answers are grouped, the results will be
input into SPSS for further analysis. Descriptive statistics of the mean averages of participants
who have daughters, the participant knowledge of HPV, and their knowledge of the HPV
vaccine will be reflected in the table data. Cronbach’s Alpha is .883 for questions 6, 7 and 14.
Tables 6, 7 and 8 will reflect the data analysis of the reliability for those three survey questions.
The bar figures reflect the data of the survey results according to the race demographic. It
became evident in reviewing the survey results that the race demographic was most significant
on the impact of the participant responses.
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CHAPTER 4
RESULTS
Figure 1 shows one of the demographic factors of race in the survey. The number of
participants who identified as white were 20, while there were 23 participants who identified
as black. The descriptive statistics (Table 1, Figure 1) for the question of whether each
participant has a daughter describes the mean answer for the responses. As 1=yes, 2=no, 3=no
answer, the most common answer was yes in that 39 participants have daughters. Figure 1
shows the N Sample of 43 participants according to race.

TABLE 1 – DESCRIPTIVE STATISTICS of PARTICIPANTS
N sample of 43 mothers who do or do not have daughters.
Descriptive Statistics

N

Minimum

Maximum

Mean

Std. Deviation

None

43

1

43

22.00

12.557

{1, yes; 2, no; 3 no answer}

43

1

2

1.09

.294

{age 9-19}

43

1

3

1.21

.466

Valid N (listwise)

43
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FIGURE 1 – ETHNICITY DEMOGRAPHICS

Table 2 describes those responded to the survey question of their knowledge of HPV
and the HPV vaccine. The continuous variable for this question included: 1=very likely,
2=somewhat likely, 3=somewhat unlikely, 4=very unlikely, and 5=don’t know. The results
showed that the mean average answer was the same (2.37) for both questions which was 2 =
somewhat likely of the participants having knowledge of both HPV and HPV vaccine. Figure
2 shows that black mothers acknowledged having the greatest amount of knowledge of both
HPV and the HPV vaccine. White mothers answered most of only being somewhat unlikely of
having knowledge of the two variables (Figure 2).
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TABLE 2 – HPV & HPV VACCINE KNOWLEDGE
Those who have knowledge of HPV (1st row); those who have knowledge of HPV vaccine
(2nd row).
Descriptive Statistics
None

N

Minimum

Maximum

Mean

Std. Deviation

43

1

43

22.00

12.557

43

1

5

2.37

1.113

43

1

5

2.37

1.113

{1, very likely; 2, somewhat
likely; 3, somewhat unlikely;
4, very unlikely; 5, unsure}
{1, very likely; 2, somewhat
likely; 3, somewhat unlikely;
4, very unlikely; 5, unsure}
Valid N (listwise)

43

FIGURE 2 - HPV KNOWLEDGE
This bar graph reflects the survey participant’s knowledge of HPV. The results are
reflected by the race demographic of the participants.
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Table 3 shows the standard mean answer is 1.58 where the participants answered yes
to whether they will allow their daughter to receive the HPV vaccine and those who believe
that the vaccine should be mandatory. The standard deviation for those who will allow their
daughter to receive the vaccine is .626 while the standard deviation for those who believe the
vaccine should be mandatory is .391. The difference in standard deviations shows that
according to Figure 3, 12.5 white participants stated they would allow their daughter to
receive the vaccine while 12.5 of black participants stated that they would not allow their
daughter to receive the vaccine. Both the black and white participants were equal in stating
that they do not believe the vaccine should be mandatory (Figure 3).

Table 3 reflects the responses to the following questions: those who will allow
daughter to receive vaccine (1st row); those who believe it should be mandatory (2nd row).
TABLE 3 – PARTICIPANTS RESPONSE ON VACCINE ADMINISTRATION
One-Sample Statistics

N

Mean

Std. Deviation

Std. Error Mean

None

43

22.00

12.557

1.915

{1, yes; 2, no; 3, no answer}

43

1.58

.626

.095

{1, yes; 2, no; 3, no answer}

43

1.88

.391

.060
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FIGURE 3 – PARTICIPANT RESPONSE TO DAUGHTER RECIEVING VACCINE
This bar graph reflects the results to the question: Will you allow your daughter to
receive the HPV vaccine? The results were reflected based on the race

FIGURE 4 – PARTICIPANT RESPONSE TO MANDATORY VACCINE
This bar graph reflects those participants who believe the vaccine should be
mandatory. The results are reflected by the race demographic.
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Table 4 is the one-way ANOVA data which shows that 20 participants answered yes
to allowing their daughter to receive the HPV vaccine (significance level .764). The degrees
of freedom (df) showed that four participants had no answer in response to this question. The
degrees of freedom was the same, however, 35 participants answered no to the question as to
whether the HPV vaccine should be school mandated (significance level .461).

Table 4 reflects answers of the question regarding the knowledge level of the HPV
vaccine. The participants answered whether they would let their daughter receive the vaccine.
The third row was of those who agree whether the vaccine should be school mandated.
TABLE 4 – ANOVA DATA OF VACCINE QUESTION
Sum of

ANOVA
None

Squares
Between Groups

df

Mean Square

414.583

4

103.646

Within Groups

6207.417

38

163.353

Total

6622.000

42

.761

4

.190
.413

{1, yes; 2, no; 3, no

Between Groups

answer}

Within Groups

15.704

38

Total

16.465

42

.569

4

.142
.154

{1, yes; 2, no; 3, no

Between Groups

answer}

Within Groups

5.850

38

Total

6.419

42

F

Sig.
.634

.641

.460

.764

.923

.461
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FIGURE 5 - KNOWLEDGE OF VACCINE
This bar graph reflects the participant response of their knowledge of the HPV Vaccine
according to the race demographic.

The results of the survey suggests that a mother’s knowledge of the HPV vaccine
does have an effect on their decision to allow their daughter to receive the vaccine. The
Pearson correlation -.044 as shown in Table 5, shows that those who answered “very likely”
to having knowledge of the HPV vaccine were more likely to approve their daughter
receiving the vaccine. The data below is based on a two-tailed significance level of .777. It is
likely, that this survey can be used on a test-retest reliability basis and draw very similar
results as the participants will most likely provide the same responses. The overall theme is
that knowledge of a subject matter does play a role in how a person makes a decision.
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Table 5 reflects those who answered if they would allow their daughter to receive the
vaccine based on their knowledge of the HPV vaccine.
TABLE 5 – CORRECLATIONS
Correlations
{1, vlikely; 2,
slikely; 3,
sunlikely; 4,

{1, yes; 2, no; 3, no answer}

Pearson Correlation

{1, yes; 2, no; 3,

vunlikely; 5,

no answer}

unsure}
1

-.044

Sig. (2-tailed)

.777

N
{1, vlikely; 2, slikely; 3,

Pearson Correlation

sunlikely; 4, vunlikely; 5,

Sig. (2-tailed)

unsure}

N

43

43

-.044

1

.777
43

43

Table 6 reflects the mean and standard deviations for questions 6, 7 & 14. Question 6
asks the knowledge level of HPV. Question 7 asks the knowledge level of the HPV vaccine.
Question 14 asks the interest level of attaining more information on both HPV and the HPV
vaccine.
TABLE 6 – ITEM STATISTIC FOR QUESTIONS 6, 7 & 14
Item Statistics
Mean

Std. Deviation

N

{1, vlikely; 2, slikely; 3, sunlikely; 4,
vunlikely; 5, unsure}

8.60

5.595

5

8.80

6.535

5

8.60

7.232

5

{1, vlikely; 2, slikely; 3, sunlikely; 4,
vunlikely; 5, unsure}

{1, vlikely; 2, slikely; 3, sunlikely; 4,
vunlikely; 5, unsure}
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Table 7 reflects the Cronbach’s Alpha for questions 6, 7 and 14. Question 6 and 7
(list item 1 & 2) inquires the knowledge level of either HPV or the HPV vaccine. Question
14 (list item 3) inquires the interest level to attain more information regarding HPV and the
HPV vaccine.
TABLE 7 – CROBACH’S ALPHA
Item-Total Statistics
Cronbach's
Scale Mean if

Scale Variance

Corrected Item-

Alpha if Item

Item Deleted

if Item Deleted

Total Correlation

Deleted

{1, vlikely; 2, slikely; 3,
sunlikely; 4, vunlikely; 5,

17.40

150.300

.914

.736

17.20

136.200

.840

.772

17.40

146.800

.616

.992

unsure}
{1, vlikely; 2, slikely; 3,
sunlikely; 4, vunlikely; 5,
unsure}
{1, vlikely; 2, slikely; 3,
sunlikely; 4, vunlikely; 5,
unsure}

Table 8 analyzes the variance in the answers for questions 6, 7 and 14. These were
the questions in the survey that had a direct impact on the participant response as to whether
they will allow their daughter to receive the HPV vaccine and if it should be school
mandated.
TABLE 8 – SCALE STATISTICS FOR QUESTIONS 6, 7 & 14
Scale Statistics
Mean
26.00

Variance
307.000

Std. Deviation
17.521

N of Items
3
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CHAPTER 5
CONCLUSION
The goal of this study was to determine if or when parents should have their daughters
vaccinated for the HPV vaccine. According to the survey results, the age of the children was a
major consideration as various states have been debating if it should be a mandatory school
vaccination. The results showed that there was no demographic correlation between the
demographics of the participants specifically the race and marital status. However, as shown
in the previously recorded data in Chapter 3, the survey participants still believed that the
vaccine should not be mandatory despite their knowledge level or their willingness to allow
their daughter to receive the vaccine. The level of knowledge is what contributes to the
concerns about the HPV vaccine.
This study is an introduction to this current and rising issue and the sample size is
relatively small. The Gardasil commercial, in which the girls state that they could be “one less”
woman to develop cervical cancer, and the rumor that Gardasil was going to become a new
vaccination for middle school girls were the inspirations on the decision to implement this
small study. There are several limitations to this study. One limitation is that there weren’t
many parents who elaborated on their answers. A second limitation was that demographics
were not a factor in the validation of this study. A third limitation was that the study was only
performed in two areas within the state of Michigan, therefore, the results do not speak enough
to the general population of parental awareness of HPV and the HPV vaccine.
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In summary of the survey, the number of mothers who answered yes to the question as
to whether they would allow their daughter to receive the vaccine was 20. Only 7 mothers
believed the HPV vaccine should be school mandated. Despite any level of knowledge of both
HPV and the HPV vaccine, this study shows that it is preferred for the parent to have a choice
in the decision of having the vaccine administered to their daughter. Many parents are not
educated on the disease. Through this study, the participant answers were dominant in the
“somewhat unlikely” category of answers when asked about their knowledge of HPV and the
HPV vaccine. The level of knowledge does play a significant role in their views about the
vaccine. Another parental concern is the long and short term effects of the disease. The
education of a vaccination is important to parents because the disease could have side effects
that they may want to prevent but have no knowledge of or the disease may be one that they
will let their child decide as they get older. The vaccination may have severe side effects or
other long term effects. Additionally, the moral concern of the use of the vaccination is to be
considered as it can be viewed as a form of encouragement for children and teens to have premarital sex.
A concern regarding the acceptance of the vaccine is the mandate implemented by
various states to make the vaccine mandatory for school age girls before they enter high school.
Many parents may disagree with the vaccination because it only affects females. They may
have other issues with the climbing number of vaccinations that are mandatory in schools. An
additional concern is if parents will have the option to opt out of having their daughter take the
vaccine.
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This is clearly a topic that needs to be furthered discussed within the healthcare,
government and educational systems to make the best suited decision on the vaccine mandate.
It is also imperative to provide more educational tools to parents so they can make the right
decision for their child. Bringing awareness on HPV and the vaccine options will definitely
contribute to addressing the concerns of HPV and the potential health issues this disease can
lead towards.
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APPENDIX A
To Whom It May Concern:
I am seeking parents of girls to participate in a mini educational study by this survey
enclosed to help me complete my Masters of Education degree in Research and Evaluation. I
attend Wayne State University and am an elementary teacher with Detroit Public Schools. My
thesis is titled "Women Perception on Daughter Receive the Cervical Cancer Vaccine as a
School Mandate?” the premise came from an article that I read in the American Teacher. The
article stated that Michigan was one of the states debating if the cervical cancer vaccine,
“Gardasil”, should become a mandated vaccine for school. Therefore, I became interested in
what parents of students thought, so that brings me to asking you to participate in a mini
educational survey to help me complete my thesis. If you have any questions feel free to contact
me via e-mail: tiffany77@comcast.net subject: Gardasil. Feel free to pass it along to other
parent with daughters. The more surveys completed the better.

Educationally Yours,
Tiffany F. Davis
Wayne State Student
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APPENDIX B
Survey on Parental Choice of HPV for Daughters
1. Do you have a school age daughter?

Yes

2. If yes on question 1, continue
Is she between the age of 9- 19? Yes

No

No

3. Which age group, if more than one (1) daughter circles all that applies or complete more
than one (1) survey?
9yrs -11yrs 12yrs -15yrs 16yrs -19yrs
4. Would you allow your daughter to
receive the HPV vaccine?
Yes

No

5. Do you think it should be a mandatory?
School vaccine?
Yes

No

Very
Smwt Smwt
Likely likely unlikely

Very
unlikely

Don’t
know

6. How much do you know?
about HPV?











7. How much do you know?
about the HPV vaccine?











How likely are you to get information about HPV or the HPV vaccine from these sources?
Very
Smwt
Smwt
Very
Don’t
likely
likely
unlikely unlikely
know

8. A doctor, nurse, or health
care provider











9. Internet











10. Family members











11. Friends
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12. Magazines, books, television 



















13. School District

Very Smwt
Smwt
Very
Don’t
Likely likely unlikely
unlikely
know

14. How interested are you
in getting information
about HPV or its vaccine?











15. What is your marital status?
Married

Single

Live w/ Someone Divorced

Widowed

16. What is your race?
White

Black

Hispanic

Asian

Other
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APPENDIX C
Survey Results on Parental Choice of HPV for Daughters
1. Do you have a school age daughter? Yes (39)

No (4)

2. If yes on question 1, continue
Is she between the age of 9- 19? Yes (35)

No (8)

3. Which age group, if more than one (1) daughter circle all that applies or complete more
than one (1) survey?
9yrs -11yrs 12yrs -15yrs 16yrs -19yrs
(12)
(13)
(20)
4. Would you allow your daughter to receive the HPV vaccine?
Yes (20)
No (19) (4) Undecided
5. Do you think it should be a mandatory school vaccine?
Yes (7)
No (35)
Very
Smwt Smwt
Likely likely unlikely

Very
unlikely

Don’t
know

6. How much do you know?
about HPV?
11

10

16

3

3

11

10

18

2

3

7. How much do you know
about the HPV vaccine?

How likely are you to get information about HPV or the HPV vaccine from these sources?
Very Smwt
Smwt
Very
Don’t
Likely likely unlikely unlikely
know
8. A doctor, nurse, or health
care provider
20
15
6
1
1
9. Internet

8

13

8

6

5

10. Family members

3

8

8

15

8

13

15

10

3

2

11. Friends
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12. Magazines, books, television 3

18

8

12

2

Very
Likely

Smwt
likely

Smwt
unlikely

13. School District

5

12

7

13

6

14. How interested are you
in getting information about
HPV or its vaccine

19

11

9

4

0

Very
unlikely

15. What is your marital status?
Married (29)

Single (9) Live w/ Someone (1) Divorced (4)

Widowed(0)

16. What is your race?
White (20) Black (23)

Hispanic (0)

Asian (0)

Other (0)

Don’t
know
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ABSTRACT
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The Human Papilloma Virus also known as HPV is a sexually transmitted disease.
This particular STD consists of genital warts and can lead to cervical cancer in women. A
HPV vaccine, Gardisil has been developed to help prevent the transmission of this particular
STD. The topic of this paper is to discuss whether the HPV vaccine should be required to
administer among female girls and adolescents. Despite the fact that the HPV vaccine is a
preventative method for contracting HPV, many parents are not eager to accept this as a
required vaccine to be administered to their daughter. One of the major reasons is due to lack
of education about both HPV and the HPV vaccine. A study is performed to determine if
parents are open to their child receiving the HPV vaccine and to test their knowledge of HPV
and the HPV vaccine. The study concludes that parents do not have enough knowledge of
HPV and the HPV vaccine to agree to the mandates that are being implemented throughout
the United States to require female students to take the vaccine.
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